|
| Exchange Disseminated Time 02/11/2015 18:04:48 | Concord Drugs Ltd has informed BSE that the meeting of the Board of Directors of the Company will be held on November 14, 2015, inter alia, to consider the following:
1. Unaudited financial results for the quarter and year ended September 30, 2015.
2. Limited Review report for the quarter ended September 30, 2015.
Further, as per the Company’s internal Code for Prevention of Insider Trading (as amended) the trading window for dealing in the securities of the Company is closed for the Company's Directors / Officers and designated employees of the Company from November 04, 2015 and will re-open 48 hours after the publication of the September quarter results to the public in the Board Meeting scheduled to be held on November 14, 2015. |
|
|